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The location of effective contacts during deep brain stimulation (DBS) is still debated 
in particular in the sub thalamic area. 
Objectives: To localise on 1.5 T MRI, the effective contacts in patients successfully 
treated for Parkinson’s disease by bilateral DBS of the sub thalamic nucleus (STN). 
Material and methods: Ten patients with excellent clinical outcome were analysed. The 
surgical procedure was based on direct targeting of the nucleus (anatomic targeting 
without reference to internal landmarks). The effective contacts were determined 
during the first 6 months following the implantation, i.e. those given the best efficacy 
on the clinical symptoms (mean improvement rate 82.5%, range 75.8–94.1%). The 
contact locations were retrospectively projected on the stereotactic 1.5 T MRI (3 sets, 
orthogonal plans), i.e. with a stereotactic frame. For each patient, we have 
distinguished the right and the left hemisphere. The location of the effective contacts 
was directly studied by visual comparison, between the 1.5 T images and an in-house 
4.7 T MRI anatomic reference. The membership for a given structure was determined 
using the results for each orthogonal, independent plan. 
Results: The effective contact were located within the STN in 4 cases, at the interface 
of the STN and the zona incerta (ZI) and/or the Forel’s field (FF) in 12 cases, at the 
interface between ZI and FF in 3 cases, at the interface between the STN and the 
substantia nigra in one case. 
Discussion: The dorsolateral part of the STN is usually considered as the target for 
DBS in Parkinson’s disease. We discuss the role of adjacent structures, especially ZI 
and FF, in the clinical benefit. A largest study, including 56 patients is already in 
progress to assess and to refine these results. 
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